Your browser doesn't support javascript.
loading
Test-Retest Reliability of the BREAST-Q IS in the Australian Breast Device Registry.
Merenda, Michelle; Vishwanath, Swarna; Ng, Sze; Parker, Emily; Earnest, Arul; Klassen, Anne; Pusic, Andrea; Hopper, Ingrid.
Afiliación
  • Merenda M; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Vishwanath S; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Ng S; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Parker E; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Earnest A; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Klassen A; Department of Pediatrics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Pusic A; Brigham and Women's Hospital, Boston, MA, USA.
  • Hopper I; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Aesthet Surg J ; 41(4): NP177-NP184, 2021 03 12.
Article en En | MEDLINE | ID: mdl-33289030
ABSTRACT

BACKGROUND:

Patient-reported outcome measures (PROMs) are increasingly employed in healthcare to assess outcomes. The BREAST-Q Implant Surveillance module (BREAST-Q IS) is a 5-question PROM utilized by the Australian Breast Device Registry to monitor the performance of breast devices. Validation of this tool is needed to assess its utility in this setting.

OBJECTIVES:

The objective of this study was to assess the test-retest reliability of the BREAST-Q IS among breast implant recipients within a registry setting.

METHODS:

A test-retest reliability study was undertaken. Patients who underwent breast augmentation or breast reconstruction and registered with the Australian Breast Device Registry were eligible to participate. A total of 250 surveys were distributed. The BREAST-Q IS was administered to the same group of participants on 2 separate occasions with a 2-week test interval. Participants were divided into 2 groups breast augmentation and breast reconstruction. A weighted kappa coefficient was calculated to assess the degree of test-retest reliability of the BREAST-Q IS.

RESULTS:

A total of 207 participants completed both tests. The response rate was 82% (n = 113) for the breast augmentation group and 94% (n = 94) for the breast reconstruction group. All 5 questions on the BREAST-Q IS obtained weighted kappa scores above 0.74 among both groups.

CONCLUSIONS:

The BREAST-Q IS has good to excellent test-retest reliability for utilization among breast implant recipients in a registry setting. Further validation of the BREAST-Q IS will be required to establish the BREAST-Q IS as a valid and reliable PROM tool for breast implant recipients following breast device surgery.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Satisfacción del Paciente / Mamoplastia Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Aesthet Surg J Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Satisfacción del Paciente / Mamoplastia Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Aesthet Surg J Año: 2021 Tipo del documento: Article País de afiliación: Australia